Numinus Wellness Provides Update Regarding Listing Status

Core Viewpoint - Numinus Wellness Inc. is set to be delisted from the Toronto Stock Exchange (TSX) effective April 22, 2026, following a decision by the TSX Continued Listing Committee, which aligns with prior shareholder authorization and the company's strategic considerations [3]. Group 1: Delisting and Listing Status - The delisting from the TSX is not a result of a request from the company but is consistent with shareholder authorization granted during the annual general meeting on August 28, 2025 [2][3]. - The company is currently under a cease trade order (CTO), which means that the delisting will not change the current trading status of its securities, which are not tradable in Canada [4]. - Numinus has filed an application to list its shares on the Canadian Securities Exchange (CSE), which is contingent upon the revocation of the CTO and meeting CSE's listing requirements [5]. Group 2: Company Focus and Strategy - Numinus is focused on innovative mental health care, particularly through evidence-based psychedelic-assisted therapies aimed at treating conditions such as depression, anxiety, trauma, pain, and substance use [6]. - The management's primary strategy is to restore trading, enhance shareholder liquidity, and position the company for its next phase of growth [5].